Literature DB >> 17896620

Dynamics of knockdown pyrethroid insecticide resistance alleles in a field population of Anopheles gambiae s.s. in southwestern Nigeria.

T S Awolola1, A O Oduola, I O Oyewole, J B Obansa, C N Amajoh, L L Koekemoer, M Coetzee.   

Abstract

BACKGROUND &
OBJECTIVES: Pyrethroid insecticide resistance in the malaria vector Anopheles gambiae Giles is mainly associated with reduced target site sensitivity arising from a single point mutation in the sodium channel gene, often referred to as knockdown resistance (kdr). This resistance mechanism is widespread in West Africa and was reported for the first time in Nigeria in 2002. Here we present changes in the susceptibility/resistance status of the molecular 'M' and 'S' forms of An. gambiae and the frequency of the kdr alleles from 2002-05.
METHODS: Adult anophelines were sampled quarterly inside human dwellings from January 2002 to December 2005 and adults reared from wild larvae were identified using morphological keys. Samples belonging to the An. gambiae complex were subjected to PCR assays for species identification and detection of molecular 'M' and 'S' forms. Insecticide susceptibility tests were carried out using standard WHO procedures and test kits only on 2-3 days old adult An. gambiae s.s. reared from larval collections. The kdr genotypes were determined in both live and dead specimens of An. gambiae s.s. using alleles-specific polymerase chain reaction diagnostic tests.
RESULTS: The overall collection showed that the molecular 'S' form was predominant (> 60%) but the proportions of both forms in the mosquito populations from 2002-05 were not statistically different. Both forms also occurred throughout the period without apparent relationship to wet or dry season. Insecticide susceptibility tests did not show any significant increase in the resistance status recorded for either Permethrin or DDT from 2002-05, rather, an improvement in the susceptibility status of the mosquitoes to these insecticides was observed from 2004-05 relative to the tests performed in 2002-03.
CONCLUSION: The proportion of the molecular 'M' and 'S' form of An. gambiae and the kdr frequencies have not increased significantly from 2002 when it was first reported in Nigeria. However, the findings on susceptible mosquitoes exhibiting the kdr gene need further investigation. Further monitoring of this may provide additional information on the ongoing debate on the possibility of restriction in gene flow and reproductive barriers in these sympatric taxa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17896620

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  24 in total

1.  Comparative analyses reveal discrepancies among results of commonly used methods for Anopheles gambiaemolecular form identification.

Authors:  Federica Santolamazza; Beniamino Caputo; Maria Calzetta; José L Vicente; Emiliano Mancini; Vincenzo Petrarca; João Pinto; Alessandra della Torre
Journal:  Malar J       Date:  2011-08-02       Impact factor: 2.979

2.  Spatio-temporal patterns in kdr frequency in permethrin and DDT resistant Anopheles gambiae s.s. from Uganda.

Authors:  Katrijn Verhaeghen; Wim Van Bortel; Patricia Roelants; Paul Edward Okello; Ambrose Talisuna; Marc Coosemans
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Insecticide susceptibility of Anopheles coluzzii and Anopheles gambiae mosquitoes in Ibadan, Southwest Nigeria.

Authors:  P N Okorie; O G Ademowo; H Irving; L A Kelly-Hope; C S Wondji
Journal:  Med Vet Entomol       Date:  2014-11-22       Impact factor: 2.739

4.  Evidence of carbamate resistance in urban populations of Anopheles gambiae s.s. mosquitoes resistant to DDT and deltamethrin insecticides in Lagos, South-Western Nigeria.

Authors:  Adedayo O Oduola; Emmanuel T Idowu; Muyiwa K Oyebola; Adedapo O Adeogun; Judith B Olojede; Olubunmi A Otubanjo; Taiwo S Awolola
Journal:  Parasit Vectors       Date:  2012-06-11       Impact factor: 3.876

5.  The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic précis.

Authors:  Marianne E Sinka; Michael J Bangs; Sylvie Manguin; Maureen Coetzee; Charles M Mbogo; Janet Hemingway; Anand P Patil; Will H Temperley; Peter W Gething; Caroline W Kabaria; Robi M Okara; Thomas Van Boeckel; H Charles J Godfray; Ralph E Harbach; Simon I Hay
Journal:  Parasit Vectors       Date:  2010-12-03       Impact factor: 3.876

6.  Kdr-based insecticide resistance in Anopheles gambiae s.s populations in.

Authors:  Philippe Nwane; Josiane Etang; Mouhamadou Chouaїbou; Jean Claude Toto; Rémy Mimpfoundi; Frédéric Simard
Journal:  BMC Res Notes       Date:  2011-10-28

7.  Nigeria Anopheles vector database: an overview of 100 years' research.

Authors:  Patricia Nkem Okorie; F Ellis McKenzie; Olusegun George Ademowo; Moses Bockarie; Louise Kelly-Hope
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

8.  Trends in DDT and pyrethroid resistance in Anopheles gambiae s.s. populations from urban and agro-industrial settings in southern Cameroon.

Authors:  Philippe Nwane; Josiane Etang; Mouhamadou Chouaibou; Jean Claude Toto; Clément Kerah-Hinzoumbé; Rémy Mimpfoundi; Herman Parfait Awono-Ambene; Frédéric Simard
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

Review 9.  Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis.

Authors:  Dziedzom K de Souza; Benjamin Koudou; Louise A Kelly-Hope; Michael D Wilson; Moses J Bockarie; Daniel A Boakye
Journal:  Parasit Vectors       Date:  2012-11-14       Impact factor: 3.876

10.  Insecticide resistance in Anopheles gambiae from south-western Chad, Central Africa.

Authors:  Clément Kerah-Hinzoumbé; Mallaye Péka; Philippe Nwane; Issa Donan-Gouni; Josiane Etang; Albert Samè-Ekobo; Frédéric Simard
Journal:  Malar J       Date:  2008-09-29       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.